Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
36
RXRX Quote, Financials, Valuation and Earnings
Last price:
$5.52
Seasonality move
:
-20.8%
Day range:
$5.21 - $5.56
52-week range:
$3.79 - $12.36
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
28.48x
P/B ratio:
2.35x
Volume:
24.4M
Avg. volume:
31.9M
1-year change:
-37.33%
Market cap:
$2.2B
Revenue:
$58.5M
EPS (TTM):
-$1.77
Earnings Data
Next earnings date for RXRX
Aug 08
2025
Most recent earnings per share
-$0.50
Beat by $0.02
(May 5/2025)
Consensus Estimate
-$0.52
(May 5/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
RXRX Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 | $20M | -- | -- | -- | -- |
| 08/08/2025 | Q2 | $16.2M | -- | -- | -- | -- |
| 05/05/2025 | Q1 | $18.1M | $14.8M | -$0.50 | -$0.52 | $0.02 |
| 02/28/2025 | Q4 | $19M | $4.5M | -$0.53 | -$0.42 | -$0.11 |
| 11/06/2024 | Q3 | $29.8M | $26.1M | -$0.34 | -$0.33 | -$0.01 |
| 08/08/2024 | Q2 | $13.3M | $14.4M | -$0.40 | -$0.38 | -$0.02 |
| 05/09/2024 | Q1 | $13.1M | $13.5M | -$0.39 | -$0.43 | $0.04 |
| 02/27/2024 | Q4 | $20.4M | $10.6M | -$0.42 | -$0.45 | $0.03 |
| 11/09/2023 | Q3 | -- | -- | -$0.43 | -$0.39 | -$0.04 |
| 08/08/2023 | Q2 | -- | -- | -$0.38 | -$0.37 | -$0.01 |
| 05/08/2023 | Q1 | -- | -- | -$0.34 | -$0.35 | $0.01 |
| 02/27/2023 | Q4 | -- | -- | -$0.31 | -$0.24 | -$0.07 |
| 11/08/2022 | Q3 | -- | -- | -$0.35 | -$0.38 | $0.03 |
| 08/09/2022 | Q2 | -- | -- | -$0.38 | -$0.37 | -$0.01 |
| 05/10/2022 | Q1 | -- | -- | -$0.33 | $0.51 | -$0.84 |
| 03/23/2022 | Q4 | -- | -- | -$0.38 | -$0.31 | -$0.07 |
| 11/10/2021 | Q3 | -- | -- | -$0.28 | -$0.28 | $0.00 |
| 08/13/2021 | Q2 | -- | -- | -$0.31 | -$0.24 | -$0.07 |
| 03/31/2021 | Q1 | -- | -- | -$0.20 | -$0.23 | $0.04 |
| 12/31/2020 | Q4 | -- | -- | -$0.23 | -- | -- |
| 06/30/2020 | Q2 | -- | -- | -$0.17 | -- | -- |
| 03/31/2020 | Q1 | -- | -- | -$0.16 | -- | -- |
Recursion Pharmaceuticals Earnings Questions
-
How Much did Recursion Pharmaceuticals Generate in Revenue Last Quarter?
Recursion Pharmaceuticals reported $14.8M worth of top line sales in its most recent quarter.
-
Did Recursion Pharmaceuticals Beat Earnings Last Quarter?
Recursion Pharmaceuticals announced earnings per share of -$0.50 which represents a beat of analyst forecast a -$0.52 per share.
-
Is Recursion Pharmaceuticals Profitable?
Recursion Pharmaceuticals reported -$7M that represents -$0.02 per share over the last quarter.
-
What is the Analyst Consensus for Recursion Pharmaceuticals EPS Next Year?
Recursion Pharmaceuticals's earnings are forecast to decrease from -$1.69 per share to -$1.54 per share next year representing a decrease of -13.74%.
-
When is Recursion Pharmaceuticals's Earnings Date?
Recursion Pharmaceuticals's next earnings date is August 8, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
